Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Elme Communities (WRE)
|
Add to portfolio |
|
|
|
| Price: |
$26.11
| | Metrics |
| OS: |
87.7
|
M
| |
|
|
| Market cap: |
$2.29
|
B
| |
|
|
|
|
|
| |
|
|
|
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
|
|
| |
|
|
|
|
|
| |
|
|
| EPS |
| |
|
|
|
BVPS
|
$14.21
| |
1.84
|
x P/B
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 169.2 | 176.0 | 176.7 | 291.7 | 280.3 | 313.3 | 306.4 | 288.6 |
| Revenue growth | -3.9% | -0.4% | -39.4% | 4.1% | -10.5% | 2.2% | 6.2% | 9.7% |
| Cost of goods sold | 82.8 | 86.3 | 86.2 | 105.6 | 105.4 | 115.0 | 112.2 | 140.4 |
| Gross profit | 86.3 | 89.7 | 90.5 | 186.1 | 174.9 | 198.3 | 194.2 | 148.2 |
| Gross margin | 51.0% | 50.9% | 51.2% | 63.8% | 62.4% | 63.3% | 63.4% | 51.3% |
| General and administrative | 27.5 | 24.0 | 26.1 | 22.1 | 22.6 | 19.5 | 20.1 | 19.6 |
| EBIT | -4.6 | -2.4 | 57.9 | 57.2 | 125.6 | 274.4 | 241.4 | 70.4 |
| EBIT margin | -2.7% | -1.4% | 32.7% | 19.6% | 44.8% | 87.6% | 78.8% | 24.4% |
| Pre-tax income | -53.1 | -40.3 | -4.3 | 1.2 | -3.5 | 119.9 | 89.1 | 5.0 |
| Income taxes | -69.5 | -24.6 | -387.8 | -24.5 | 0.1 | 0.6 | -0.1 | -0.1 |
| Tax rate | 130.8% | 61.1% | 9118.3% | | | 0.5% | | |
| Earnings from continuing ops | -122.7 | -65.0 | -392.1 | -23.3 | -3.5 | 119.3 | 89.7 | 5.1 |
| Earnings from discontinued ops | 69.5 | 24.6 | 387.8 | 24.5 | 23.2 | | | 106.5 |
| Net income | -53.1 | -40.3 | -4.3 | 1.2 | 19.7 | 119.3 | 89.7 | 111.6 |
| Net margin | -31.4% | -22.9% | -2.4% | 0.4% | 7.0% | 38.1% | 29.3% | 38.7% |
| |
| Diluted EPS | ($1.45) | ($0.79) | ($4.89) | ($0.30) | ($0.05) | $1.65 | $1.31 | $0.08 |
| Shares outstanding (diluted) | 84.5 | 82.3 | 80.3 | 79.0 | 76.8 | 72.3 | 68.3 | 66.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|